HIV cure a possibility in the next 20 years, GSK and US scientists collaborate

Scientists from across the world have been trying to design new methods of preventing AIDS, but there has hardly been any talk about curing this deadly disease that affects 35 million people worldwide. For long now, usage of a lifetime usage of anti-retroviral therapy has helped keeping HIV at bay, and hence scientists believe that a cure for HIV is possible. (Read: 11 interesting facts about HIV/AIDS you didn't know!)

To find a cure for a deadly disease like HIV, Britain's GlaxoSmithKline and the University of North Carolina at Chapel Hill will be establishing a new jointly owned company. GSK is expected to invest $20 million for funding the work for an initial five years.

The 'shock and kill' strategy developed by the University, which reveals the dormant HIV hiding in white blood cells, will be closely studied as a cure option. (Read: HIV diagnosis - everything you should know about )

Also Read

More News

As reported by Reuters, GSK's infectious diseases head, Zhi Hong said that the next five to ten years would be crucial to understanding various mechanisms that could contribute to a cure and in the next 10-20 years these methods could be merged to could find the cure.

Image source: Getty Images

For more articles on diseases & conditions, visit our diseases & conditions section. For daily free health tips, sign up for our newsletter.

Stay Tuned to TheHealthSite for the latest scoop updates

Join us on